COVID-19 and the immune response: A multi-phasic approach to the treatment of COVID-19
T Sapir, Z Averch, B Lerman, A Bodzin… - International Journal of …, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a viral agent that causes
Coronavirus disease 2019 (COVID-19), a disease that causes flu-like symptoms that, when …
Coronavirus disease 2019 (COVID-19), a disease that causes flu-like symptoms that, when …
The breadth of the neutralizing antibody response to original SARS‐CoV‐2 infection is linked to the presence of Long COVID symptoms
AM Buck, AN Deitchman, S Takahashi… - Journal of Medical …, 2023 - Wiley Online Library
The associations between longitudinal dynamics and the breadth of SARS‐CoV‐2
neutralizing antibody (nAb) response with various Long COVID phenotypes before …
neutralizing antibody (nAb) response with various Long COVID phenotypes before …
Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to …
Z Ren, M Nishimura, LH Tjan, K Furukawa… - PLoS …, 2022 - journals.plos.org
Continuous appearance of SARS-CoV-2 variants and mass vaccination have been
intricately influencing on the COVID-19 situation. To elucidate the current status in Japan …
intricately influencing on the COVID-19 situation. To elucidate the current status in Japan …
A DNA vaccine encoding the full-length spike protein of beta variant (B. 1.351) elicited broader cross-reactive immune responses against other SARS-CoV-2 variants
G Zhao, Z Zhang, Y Ding, J Hou, Y Liu, M Zhang, C Sui… - Vaccines, 2023 - mdpi.com
The SARS-CoV-2 pandemic remains an ongoing threat to global health with emerging
variants, especially the Omicron variant and its sub-lineages. Although large-scale …
variants, especially the Omicron variant and its sub-lineages. Although large-scale …
Cross-neutralizing activity against Omicron could be obtained in SARS-CoV-2 convalescent patients who received two doses of mRNA vaccination
Y Kurahashi, K Furukawa, S Sutandhio… - The Journal of …, 2022 - academic.oup.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant omicron is now
under investigation. We evaluated cross-neutralizing activity against omicron in coronavirus …
under investigation. We evaluated cross-neutralizing activity against omicron in coronavirus …
Factors Associated with SARS-CoV-2 Infection Evaluated by Antibody Response in a Sample of Workers from the Emilia-Romagna Region, Northern Italy
S Paduano, M Granata, S Turchi, A Modenese… - Antibodies, 2023 - mdpi.com
Factors associated with SARS-CoV-2 infection risk are still debated. This case–control study
aims to investigate the possible relationship between SARS-CoV-2 infection, evaluated …
aims to investigate the possible relationship between SARS-CoV-2 infection, evaluated …
Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ. 1.1 and XBB, in a very elderly population
S Sutandhio, K Furukawa, Y Kurahashi… - Journal of Infection and …, 2023 - Elsevier
Background Omicron variants with immune evasion have emerged, and they continue to
mutate rapidly, raising concerns about the weakening of vaccine efficacy, and the very …
mutate rapidly, raising concerns about the weakening of vaccine efficacy, and the very …
Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual
J Li, L Zou, S Li, R Zou, Z Fang, P Zhang, H Li… - Viral …, 2023 - liebertpub.com
We investigated the persistence of SARS-CoV-2-specific neutralizing antibodies in serum
(CoV-2-SNAb) against the “WH-Human 1” coronavirus in 57 convalescent persons from …
(CoV-2-SNAb) against the “WH-Human 1” coronavirus in 57 convalescent persons from …
Novel monoclonal antibodies showing broad neutralizing activity for SARS-CoV-2 variants including Omicrons BA. 5 and BA. 2.75
H Ishimaru, M Nishimura, LH Tjan, S Sutandhio… - bioRxiv, 2022 - biorxiv.org
We identified novel neutralizing monoclonal antibodies against SARS-CoV-2 variants
(including Omicron) from individuals received two doses of mRNA vaccination after they had …
(including Omicron) from individuals received two doses of mRNA vaccination after they had …
Gamma Delta T cell Responses to Diverse Diseases: Tuberculosis, Cancer and COVID-19
A Morrison - 2024 - search.proquest.com
Abstract γδ T cells are unconventional cells involved in innate and adaptive immunity. They
are able to respond rapidly and have roles in a range of diseases. The tuberculosis (TB) …
are able to respond rapidly and have roles in a range of diseases. The tuberculosis (TB) …